UK Investor Show video – Concepta (#CPT)
- 2019-04-17 07:00:00
Nine days ago Concepta (CPT) was pushing aggressively at UK Investor - having just re-announced a deal with Boots - and mug punters responded, paying up to 3.75p to buy shares in the market. Last week I was made an insider. Apparently two big funds were desperate for shares and a placing to raise £2 million was underway...
The great success that was the 2019 Global Group UK Investor Show saw three 'Dragon's Den' sessions where a number of CEOs each gave a 1 minute (well, supposed to be!) pitch and three 'Dragons' at each session each picked a stock for a £1,000 investment. These have now been purchased, so what were the picks (& can 12 year-old Leela show the other dragons how intelligent investing is done these days)?...
We've noted that the new boss of Concepta (CPT), Matthew Walls, is a class act and he is showing it. Costs have been cut, the Chinese malarkey ended and the focus has been on monetising the MyLotus kit, which tells women exactly when the time is right to get up the duff. The reviews of MyLotus from women who have used it have been rave reviews. The question was: how to get it to market?...
This did not take long. CE-Mark approval on Monday, UK launch of Mylotus this weekend coming. Concepta (CPT) and its new boss Matthew Walls have been hard at work...
The China gambit did not work out too well. But Concepta (CPT) has a new – very well regarded – chairman in Matthew Walls, its balance sheet has been sorted by a placing and now we are on the verge of real sales and a ramp up towards and into profitability. For the company has now announced that it has received UK CE-Mark certification for its myLotus branded products for women's fertility.
July-joined Chairman of women's fertility home test platform company Concepta (CPT), Matthew Walls is “pleased to report the half year results for the six months to 30 June 2018”. He shouldn’t be…
Tom Winnifrith was an insider on this one but opted not to participate in the placing after all the grief he got for taking part on the Premaitha (NIPT) placing at 4.5p a couple of months ago. Premaitha shares are now 9.9p and that is what you may wish to consider.
Concepta (CPT) has announced results for 2017, emphasising “although progress has been slower than anticipated, we have built robust foundations in China and are well on our way to launching in the EU”…
Maybe the idiom is a bad one but it is meant to signify that Concepta (CPT) is making steady progress towards a real lift off in sales and profits. The latest news is from the UK and is that it has achieved ISO13485 certification for its manufacturing site in Doncaster. So what you say?
Concepta (CPT) has made an announcement commencing that it “is pleased to announce that it showcased its myLotus products at the Manchester Fertility Show on 24 and 25 March 2018”. Not exactly a groundbreaking occurrence!... but the company also “announced the forthcoming launch of its myLotus products in the UK at the event”…









